基于SWOT分析的药食同源产业发展策略研究
投稿时间:2024-06-12     点此下载全文
引用本文:程蒙,唐晓晶,周修腾,李颖,陈敏,高峰.基于SWOT分析的药食同源产业发展策略研究[J].中国现代中药,2024,26(11):1823-1832
DOI:10.13313/j.issn.1673-4890.20240612004
摘要点击次数: 119
全文下载次数: 0
                 
作者中文名作者英文名单位中文名单位英文名E-Mail
程蒙 CHENG Meng 中国中医科学院 中药资源中心 道地药材品质保障与资源持续利用全国重点实验室,北京 100700 State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing100700, China  
唐晓晶 TANG Xiao-jing 中国中医科学院 中药资源中心 道地药材品质保障与资源持续利用全国重点实验室,北京 100700 State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing100700, China  
周修腾 ZHOU Xiu-teng 中国中医科学院 中药资源中心 道地药材品质保障与资源持续利用全国重点实验室,北京 100700 State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing100700, China  
李颖 LI Ying 中国中医科学院 中药资源中心 道地药材品质保障与资源持续利用全国重点实验室,北京 100700 State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing100700, China  
陈敏 CHEN Min 中国中医科学院 中药资源中心 道地药材品质保障与资源持续利用全国重点实验室,北京 100700 State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing100700, China  
高峰* GAO Feng 中国中医科学院 西苑医院,北京 100091 Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing100091, China  
基金项目:中国中医科学院科技创新工程项目(CI2021A03704)
中文摘要:为厘清药食同源产业发展现状,以药食同源物质为切入点进行比较分析,发现枸杞子、灵芝、西洋参、黄芪、茯苓、人参、当归等药食同源品种在大健康产品中被广泛应用,具有巨大的市场潜力,但以其为原料加工而成的产品却缺乏市场竞争力。采用SWOT分析框架,对药食同源产业发展的优势、劣势、机遇和挑战进行分析,发现药食同源产业发展具有管理制度不断完善、制造工艺精良、群众基础广泛等优势,面临中医药特色优势渗透不够、药食同源物质质量标准缺失、产品低水平重复开发、企业普遍存在重营销轻研发等问题,建议加强基础研究、创新产品形态、完善质量标准、突出中医药特色,从而促进药食同源产业优化升级,引导产业内涵式高质量发展。
中文关键词:药食同源  SWOT分析  产业发展  策略研究
 
Development Strategy of Medicine and Food Homology Industry Based on SWOT Analysis
Abstract:This article took the materials of medicine and food homology as a breakthrough point to clarify the development status of the medicine and food homology industry. The results showed that the materials of medicine and food homology were widely used in big health products and demonstrated great market potential. However, the products prepared from these materials lacked market competitiveness. The strength, weakness, opportunity, and threat (SWOT) analysis was then performed to evaluate the strengths, weaknesses, opportunities, and threats of the medicine and food homology industry. The results showed that the strengths included the continuous improvement of policy and regulatory frameworks, advanced manufacturing techniques, and a solid foundation of public acceptance. Meanwhile, the development of this industry faced the problems of insufficient penetration of the special advantages of traditional Chinese medicine (TCM), lack of quality standards for the materials of medicine and food homology, low-level repeated development of products, and over emphasis on marketing but insufficient efforts to research and development. It is imperative to enhance basic research, create new product types, establish quality standards, and emphasize the distinctive characteristics of TCM. These measures would promote the optimization and upgrading the industry, steer it toward high-quality and connotative development, and ultimately propel the advances of this industry.
keywords:medicine and food homology  SWOT analysis  industrial development  strategy research
查看全文   查看/发表评论  下载PDF阅读器